Dec. 11 at 2:22 AM
$OBIO [Again] Partnerships with
$MDT and
$LGND, 137 global patents, breakthrough device designation, Cash runway to 1H-2027 with
$95M Cash/ST against
$61M Total Liabilities. Avg PT:
$13.8 and currently trading at
$4.75. TD Cowen just provided its forecast (PT) at
$15.
https://www.stocktitan.net/news/OBIO/orchestra-bio-med-announces-avim-therapy-and-virtue-sab-program-7359wz18v149.html